A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
Public ClinicalTrials.gov record NCT05591079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of CS0159 in the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH)
Study identification
- NCT ID
- NCT05591079
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Cascade Pharmaceuticals, Inc
- Other
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Interventions
- CS0159 (Linafexor) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 9, 2023
- Primary completion
- Nov 8, 2023
- Completion
- Nov 8, 2023
- Last update posted
- Nov 20, 2023
2023
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Research Institute - Gardena | Gardena | California | 90247-3586 | — |
| Velocity Clinical Research, Huntington Park | Huntington Park | California | 90255-2959 | — |
| Velocity Clinical Research - Panorama City | Panorama City | California | 91402-3022 | — |
| Velocity Clinical Research - Santa Ana | Santa Ana | California | 92704 | — |
| Ocala GI Research | Lady Lake | Florida | 32159 | — |
| Florida Research Institute | Lakewood | Florida | 34211-4930 | — |
| San Marcus Research Clinic, Inc - Miami | Miami | Florida | 33014-5602 | — |
| Floridian Clinical Research, LLC - Miami Lakes | Miami Lakes | Florida | 33016-1518 | — |
| Gastroenterology Associates of Ocala | Ocala | Florida | 34471 | — |
| Oracle Clinical Research | College Park | Georgia | 30349 | — |
| Metropolitan Gastroenterology Associates - Westbank Office and Endoscopy | Marrero | Louisiana | 70072 | — |
| Raja M. Din MD, PLLC - Gastroenterology & Hepatology | Greenbelt | Maryland | 20770-6702 | — |
| Lucas Research | Morehead City | North Carolina | 28557 | — |
| Texas Liver Institute (TLI) - Austin | Austin | Texas | 78757-7571 | — |
| Pioneer Research Solutions Inc - Houston - Stancliff Rd | Houston | Texas | 77099-4307 | — |
| The Texas Liver Institute, Inc. | San Antonio | Texas | 78215 | — |
| Clinical Trials of Texas, LLC | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05591079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05591079 live on ClinicalTrials.gov.